University Journal of Pre and Paraclinical Sciences
Pattern Visual Evoked Potentials as a tool to assess the prognosis in Type 2 Diabetes Mellitus subjects attending a tertiary care hospital.
Abstract
Abstract : Introduction Type- 2 Diabetes
Mellitus (DM) is one of the most serious
challenges to healthcare, primarily because
of the increase in the prevalence of
sedentary life styles and obesity. Neuropathies
are the common complications of
type 2 DM. Visual Evoked Potentials can
be used to evaluate the disturbances in
the CNS with a simple, sensitive and noninvasive
methodology. Aim To evaluate
the conduction in optic pathway in type 2
DM patients and compare with that of
healthy controls. Objectives To use VEP
as a tool to assess the conduction in the
optic nerve in study subjects and controls
and to correlate the latency P 100 with glycosalated
haemoglobin. Study Design
Cross-sectional study. Material and Methods
The present study was conducted on
the study group of 30 type 2 DM subjects
and other group of 30 healthy age and
gender matched controls. The patients
with reduced visual acuity which was not
correctable with lenses and with retinopathy
were excluded. VEP was recorded by
using pattern reversal stimulation with
Neuro Perfect Plus POLYRITE.
Full Text:
PDFReferences
Dennis L. Kasper, Eugene
Braunwald, Anthony S. Fauci,
Stephen L. Hauser, Dan L. Longo,
J. Larry Jameson, and Kurt J. Isselbacher,
Editors. Harrison's Principles
of Internal Medicine Sixteenth
Edition, 2005.Chapter 8
Page no: 1123 – 1156.
AJE, Sicree RA, Zimmet PZ:
Global estimates of the prevalence
of diabetes for 2010 and 2030.
Diabetes Res Clin Pract 2010, 87
(1):4-14.
King H, Aubert RE, Herman WH: Global
burden of diabetes, 1995-2025: prevalence-
numerical-estimates,-andprojections.-
Diabetes-care-1998, 21 (9):
-1431.
Brussels: Gan D, International Diabetes
Federation: Diabetes Atlas. 2nd edition.
Ed. Belgium; 2003.
Zhaolan Liu, Chaowei Fu, Weibing
Wang and Biao Xu. Prevalence of
chronic complications of type 2 diabetes
mellitus in outpatients- a cross-sectional
hospital based survey in urban China.
Health and Quality of Life Outcomes
, 8:62
Woltman HW, Wilder RM. Diabetes
mellitus. Pathological changes in the spinal
cord and peripheral nerves. Arch Intern
Med 1929; 44:576-603.
Reske- Nielsen E, Lundback K, Rafaelsen
OJ. Pathological changes in the central
and peripheral nervous system of
young long term diabetics. Diabetic encephalopathy.
Diabetologia 1966;1: 233-
Tavormina JG, Kastner LS, Slater PM,
Watts SLJ Abnorm Child Psychol 1976; 4
(2):99-110.
Shagan BP. Med Clin North Am 1976;
(6):1209-11. 6. Jadzinsky M, Faerman
I, Fox D. Acta Diabetol Lat 1973; X: 208-
Jadzinsky M, Faerman I, Fox D.Acta
Diabetol Lat 1973; X: 208 – 60.
Chokroverty S. AAEE Case Report #
: Diabetic Amyotrophy. Muscle &
Nerve., 1987, 10: 679-684.
2Carsten R.E., Whalen L.R., Ishii
D.N. Impairment of Spinal Cord
Conduction Velocity in Diabetic
Rats. Diabetes, 1989, 38 (6): 730-
Comi G. Evoked potentials in diabetes
mellitus. Clin.Neurosci. 1997 4
(6): 374-9.
Di Mario U, Morano S, Valle E,
Pozzessere G. Electrophysiological
alterations of the central nervous
system in diabetes mellitus.
[Review]. Diabetes Metab Rev 1995;
: 259–77.
Rubini R, Biasiolo F, Fogarolo F,
Magnavita V, Martini A, Fiori
MG.Brainstem auditory evoked potentials
in rats with streptozotocin
induced diabetes. Diabetes Res Clin
Pract 1992; 16: 19–25.
Sima AA, Zhang WX, Cherian
PV, Chakrabarti S. Impaired visual
evoked potential and primary
axonopathy of the optic nerve in the
diabetic BB/W-rat. Diabetologia
; 35: 602–7.
`
Terada M, Yasuda H, Kikkawa R,
Koyama N, Yokota T, ShigetaY.
Electrophysiological study of dorsal
column function in streptozotocininduced
diabetic rats: comparison
with 2, 5-hexanedione intoxication. J
Neurol Sci 1993; 115: 58–66
Carsten RE, Whalen LR, Ishii
DN. Impairment of spinal cord conduction
velocity in diabetic rats. Diabetes
; 38: 730–6.
UK Misra, J Kalita In: History of Clinical
Neurophysiology. Clinical Neurophysiology,
nd Ed2005, Elsevier, New Delhi
Chapter 1: Page 1-7, Chapter 2, chapter 8
page 309 - 327.
Vinik AI, Holland MT, Le Beua JM,
Liuzzi FJ, Satnsberry KB, Colen LB. Diabetic
neuropathies. Diabetic care 1992; 15
(12): 1926-1951.10. Soliman E. Diabetic
neuropathy. Medicine Journal
;Bergamaschi R, Versino M, Callieco
R. Multimodal evoked potentials in diabetics.
Acta Neurol 13 (3): 228-235, 1991.
Chippa KH, Ropper HA. Evoked potentials
in clinical medicine. Eng Med 306:
-1150, 1982.
Spehlman R. Evoked potential primer.
Boston, Butterworth Publisher, 1987, 204-
Colin Binnie, Ray Cooper, Francois
Mauguiere, John Osselton, Pamela Prior
and Brian Tedman. Clinical Neurophysiology,
Volume 1 Revised and Enlarged edition,
Edited by: Elsevier. Part 3: Page 353
– 615.
Michael J. Aminoff Electro diagnosis in
clinical neurology. Fifth edition. Elsevier
Chap 23: Page 490-492.
Thomas H Brannagan, Louis H Weimer,
and Norman Lator. Acquired neuropathies,
Merritt’s neurology, 11th edition, Lewis P
Rowland, Philadelphia; page 761.
Sugimura K, Dyck PJ. Sural nerve myelin
thickness and axis cylinder caliber inhuman
diabetes. Neurology. 1981; 31:1087-
71. Johnson PC, Doll SC, Cromey
DW. Pathogenesis of diabetic neuropathy.
Ann Neurol. 1986; 19:450-457.
Mulder DW, Lambert EH, Bastron
JA, Sprague RG. The neuropathies
associated with diabetes
mellitus: a clinical and electromyographic
study of 103 unselected
patients. Neurology 1961; 11; 275-
73. Bril V, Role of electrophysiological
studies in diabetic
neuropathy.Can J Neurol Sci ;
; 21: S8 – S12.
De Jong RN.Postgrad.Med
; 61 (1): 101 – 7.
Deepika Chopra , Mridu Gupta ,
K.C. Manchanda , Ram Sarup
Sharma , Rajinder Singh Sidhu A
Study of Visual Evoked Potentials
in Patients of Type-2 Diabetes Mellitus.
Journal of Clinical and Diagnostic
Research. 2011 June, Vol-5
(3): 519-522.
Odom JV, Bach M, Brigell M,
Holder GE, McCulloch DL Tormene
AP, et al. ISCEV standard
for clinical visual evoked potentials
(2009 update). Doc Ophthalmol
; 120:11-9.
Varkonyi TT, Peto T, Degi R,
Keresztes K, Lengyel C, Janaky M,
et al. Impairment of visual evoked
potentials. An early central manifestation
of diabetic neuropathy.
Diabetes Care 2002; 25:1661-2.
Dolu H, Ulas VH, Bolu E, Ozkardes
A, Odabasi Z, Ozata M, et
al. Evaluation of central neuropathy
in type II diabetes mellitus by
mutlimodal evoked potentials. Acta
Neurol Belg 2003; 103(4): 2006 -
Azal O, Ozkardes A, Onde ME,
Ozata M, Ozisik G, Corakc A, et al. Visual
Evoked Potentials in Diabetic Patients.
Tr. J. of Medical Sciences 1998;
:139-42.
Szabela DA, Loba J, Palenga-Pydyn
D, Tybark, Ruxer J, Split W.
The picture of visual evoked potentials
in type 2 diabetes mellitus. Klin Oczna
;107(7):498-501.
Li P, Yang Y. Pattern reversal visual
evoked potentials analysis in patients
with noninsulindependent diabetes mellitus.
Human Yi Ke Xve Xve Bao 2001; 26
(3):283-4.
Imam M, Shehata OH. Subclinical
central neuropathy in Type-2 diabetes
mellitus. Bull. Alex. Fac. Med 2009; 45
(1):65-73.
Refbacks
- There are currently no refbacks.
This work is licensed under a Creative Commons Attribution-NoDerivatives 4.0 International License.
An Initiative of The Tamil Nadu Dr M.G.R. Medical University